Sulfo-Cyanine5 maleimide | CAS#2242791-82-6

MedKoo Cat#: 558838 | Name: Sulfo-Cyanine5 maleimide

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sulfo-Cyanine5 maleimide is a water soluble, hydrophilic sulfo-Cyanine5 maleimide (Cy5® maleimide analog). We recommend this product for protein labeling, including labeling of antibodies as a perfect replacement for Cy5® maleimide. Labeled proteins can be easily separated from unreacted dye by gel filtration, spin column purification, dialysis, electrophoresis or chromatography.

Chemical Structure

Sulfo-Cyanine5 maleimide

CAS#2242791-82-6 (potassium)

Theoretical Analysis

MedKoo Cat#: 558838

Name: Sulfo-Cyanine5 maleimide

CAS#: 2242791-82-6 (potassium)

Chemical Formula: C38H43KN4O9S2

Exact Mass:

Molecular Weight: 803.00

Elemental Analysis: C, 56.84; H, 5.40; K, 4.87; N, 6.98; O, 17.93; S, 7.99

Price and Availability

Size	Price	Availability
5mg	USD 550.00	2 Weeks
10mg	USD 950.00	2 Weeks
25mg	USD 1,650.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

2130955-10-9 (inner) 2242791-81-5 (inner) 2301999-22-2 (sodium) 2242791-82-6 (potassium)

Synonym

IUPAC/Chemical Name

potassium 2-((1E,3E)-5-((E)-1-(6-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-6-oxohexyl)-3,3-dimethyl-5-sulfonatoindolin-2-ylidene)penta-1,3-dien-1-yl)-1,3,3-trimethyl-3H-indol-1-ium-5-sulfonate

InChi Key

KKALABHIZQXGRJ-UHFFFAOYSA-M

InChi Code

InChI=1S/C38H44N4O9S2.K/c1-37(2)28-24-26(52(46,47)48)15-17-30(28)40(5)32(37)12-8-6-9-13-33-38(3,4)29-25-27(53(49,50)51)16-18-31(29)41(33)22-11-7-10-14-34(43)39-21-23-42-35(44)19-20-36(42)45;/h6,8-9,12-13,15-20,24-25H,7,10-11,14,21-23H2,1-5H3,(H2-,39,43,46,47,48,49,50,51);/q;+1/p-1

SMILES Code

O=S(C1=CC2=C([N+](C)=C(/C=C/C=C/C=C3N(CCCCCC(NCCN4C(C=CC4=O)=O)=O)C5=C(C=C(S(=O)([O-])=O)C=C5)C/3(C)C)C2(C)C)C=C1)([O-])=O.[K+]

Appearance

Solid powder

Purity

>95% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 803.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Ji, W.; Smith, P.N.; Koepsel, R.R.; Andersen, J.D.; Baker, S.L.; Zhang, L.; Carmali, S.; Myerson, J.W.; Muzykantov, V.; Russell, A.J. Erythrocytes as Carriers of Immunoglobulin-Based Therapeutics. Acta Biomaterialia, in press. doi: 10.1016/j.actbio.2019.10.027 2. Baranova, N.; Radler, P.; Hernandez-Rocamora, V.M.; Alfonso, C.; Lopez-Pelegrin, M.; Rivas, G.; Vollmer, W.; Loose, M. FtsZ assembles the bacterial cell division machinery by a diffusion-and-capture mechanism. bioRxiv, preprint. doi: 10.1101/485656 3. Cliff, L.; Chadda, R.; Robertson, J.L. Occupancy distributions of membrane proteins in heterogeneous liposome populations. BBA Biomembranes, 2020, 1862(1), 183033. doi: 10.1016/j.bbamem.2019.183033 4. Kholodenko, I.V.; Kalinovsky, D.V.; Svirshchevskaya, E.V.; Doronin, I.I.; Konovalova, M.V.; Kibardin, A.V.; Shamanskaya, T.V.; Larin, S.S.; Deyev, S.M.; Kholodenko, R.V. Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies. Molecules, 2019, 24(21), 3835. doi: 10.3390/molecules24213835 5. h, J.; Tobin, S.; Beatty, K. Generation of CoilR Probe Peptides for VIPER-labeling of Cellular Proteins. Bio-protocol, 2019, 9(21), e3412. doi: 10.21769/bioprotoc.3412 6. Cundiff, M.D.; Hurley, C.M.; Wong, J.D.; Boscia, J.A.; Bashyal, A.; Rosenberg, J:; Reichard, E.L.; Nassif, N.D.; Brodbelt, J.S.; Kraut, D.A. Ubiquitin receptors are required for substrate-mediated activation of the proteasome's unfolding ability. Scientific Reports, 2019, 9, 14506. doi: 10.1038/s41598-019-50857-y 7. Stankowska, D.L.; Nam, M.-H.; Nahomi, R.B.; Chaphalkar, R.M.; Nandi, S.K.; Fudala, R.; Krishnamoorthy, R.R.; Nagaraj, R.H. Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma. Cell Death Discovery, 2019, 5(1), 112. doi: 10.1038/s41420-019-0194-2 8 Graham, T.G.W.; Carney, S.M.; Walter, J.C.; Loparo, J.J. A single XLF dimer bridges DNA ends during nonhomologous end joining. Nature Structural & Molecular Biology, 2018, 25(9), 877–884. doi: 10.1038/s41594-018-0120-y 9. Torres, O.B.; Duval, A.J.; Sulima, A.; Antoline, J.F.G.; Jacobson, A.E.; Rice, K.C.; Alving, C.R.; Matyas, G.R. A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids. Analytical and Bioanalytical Chemistry, 2018, 410(16), 3885–3903. doi: 10.1007/s00216-018-1060-4 10. Liu, L.; Zhang, C.; Li, Z.; Wang, C.; Bi, J.; Yin, S.; Wang, Q.; Yu, R.; Liu, Y.D.; Su, Z. Albumin binding domain fusing R/K-X-X-R/K sequence for enhancing tumor delivery of doxorubicin. Molecular Pharmaceutics, 2017, 14(11), 3739–3749. doi: 10.1021/acs.molpharmaceut.7b00497 11. Guo, L.Y.; Allu, P.K.; Zandarashvili, L.; McKinley, K.L.; Sekulic, N.; Dawicki-McKenna, J.M.; Fachinetti, D.; Logsdon, G.A.; Jamiolkowski, R.M.; Cleveland, D.W.; Cheeseman, I.M.; Black, B.E. Centromeres are maintained by fastening CENP-A to DNA and directing an arginine anchor-dependent nucleosome transition. Nature Communications, 2017, 8, 15775. doi: 10.1038/ncomms15775 12. Nemudraya, A.; Kuligina, E.; Ilyichev, A.; Fomin, A.; Stepanov, G.; Savelyeva, A.; Koval, O.; Richter, V. Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin. Oncology Letters, 2016, 12(6), 4547–4555. doi: 10.3892/ol.2016.5266 13. Bruckman, M.A.; Czapar, A.E.; VanMeter, A.; Randolph, L.N.; Steinmetz, N.F. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer. Journal of Controlled Release, 2016, 231, 103–113. doi: 10.1016/j.jconrel.2016.02.045 14. Shebl, B., Menke, D.E.; Pennella, M.; Poudyal, R.R.; Burke, D.H.; Cornish, P.V. Preparation of ribosomes for smFRET studies: A simplified approach. Archives of Biochemistry and Biophysics, 2016, 603, 118–130. doi: 10.1016/j.abb.2016.05.010